In this episode, we talk about fractional exhaled nitric oxide (FeNO) and how monitoring their FeNO levels can reduce the impact asthma has on patients’ quality of life.

We’re talking about treatment for asthma in this episode, specifically inhaled corticosteroids and patient adherence, with a look at how FeNO testing can help.

In this episode, we discuss how certain types of food affect FeNO and what information clinicians can give patients to ensure reliable results.

Knowing your patient’s FeNO level can help diagnose asthma and improve outcomes. This episode explains how to interpret FeNO test results into meaningful data for patient care, as well as savings for healthcare budgets.

In this episode of the podcast, we’re looking at a summary of the latest research into pulmonary assessment during the pandemic and how FeNO testing is not an aerosol-generating procedure so it’s safe to continue using.

Asthma exacerbations cause distress and can easily lead to a medical emergency. This episode of the podcast examines the effect that flare-ups can have on patients’ quality of life and how regular FeNO testing can help to reduce the risk.

In this episode of the podcast, we look at whether FeNO testing can be used as an alternative to sputum and blood eosinophils to support asthma diagnosis.

One of the key moments at ERS 2021 came in the form of a friendly and informative debate: FeNO* for the diagnosis of asthma in adults: Friend or foe?1 Dr Iñigo Ojanguren Arranz, from the Respiratory Department of Vall d’Hebron University Hospital in Barcelona, outlined the reasons he considers FeNO a friend. Head of Pneumology and Professor of Respiratory Medicine at the University of Liège, Renaud Louis, gave a rebuttal, asserting his thoughts on why FeNO might be a foe.